Advertisement
Meeting ReportASPET 2024 Annual Meeting Abstract - Drug Discovery and Development

PACAP(6-38) Deletants as Peptide-based PACAP Antagonists

Wenqin Xu, Abigail Keith, Wenjuan Ye, Xin Hu, Giuseppe Deganutti, Mark Henderson, Patrick Sexton and Lee Eiden
Journal of Pharmacology and Experimental Therapeutics June 2024, 389 (S3) 493; DOI: https://doi.org/10.1124/jpet.493.130936
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Meeting ReportASPET 2024 Annual Meeting Abstract - Drug Discovery and Development

PACAP(6-38) Deletants as Peptide-based PACAP Antagonists

Wenqin Xu, Abigail Keith, Wenjuan Ye, Xin Hu, Giuseppe Deganutti, Mark Henderson, Patrick Sexton and Lee Eiden
Journal of Pharmacology and Experimental Therapeutics June 1, 2024, 389 (S3) 493; DOI: https://doi.org/10.1124/jpet.493.130936
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement